Granza Bio
PrivateLast Round
Seed
Jul 10, 2024
Total Funding Raised
$7.14M
Momentum Score
25 /100
Company Overview
Granza Bio is a biotechnology company that develops a cancer therapeutics platform aimed at assisting doctors in treating autoimmune diseases by specifically targeting cancer cells to minimize toxicity and side effects, thereby providing effective treatment for cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Granza Bio Comps
Public and private peers based on sector, stage, and business model.
Granza Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 10, 2024 |
Granza Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| Ritual Capital | Seed |
| Zeno Ventures | Seed |
| Y Combinator | Seed |
| Oxford Angel Fund | Seed |
| North South Ventures | Seed |
| Felicis Ventures | Seed |
Granza Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Granza Bio's valuation, stock price, and market status.
